3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
2
Lymphoma, Large B-Cell, Diffuse
2
Inflammation
2
Head and Neck Neoplasms
2
Breast Neoplasms
2
Zollinger-Ellison Syndrome
1
Uterine Cervical Dysplasia
1
Triple Negative Breast Neoplasms
1
Stomach Ulcer
1
Neoplasms
1
Mouth Neoplasms
1
Melanoma
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, B-Cell, Marginal Zone
1
Hyperuricemia
1
Gout
1
Esophagitis, Peptic
1
Cardiovascular Diseases
1
Carcinoma, Non-Small-Cell Lung
1
Burkitt Lymphoma
1
Breast Neoplasms, Male
1
Barrett Esophagus
1
Arthritis
1
Interventions
ulixertinib
1
tislelizumab
1
talazoparib
1
serabelisib
1
sapanisertib
1
pembrolizumab
1
olaparib
1
mirdametinib
1
lenvatinib
1
erdafitinib
1
crenigacestat
1
atezolizumab
1
Ramucirumab
1
Paclitaxel
1
PM 01183
1
Injections
1
IFL protocol
1
Gemcitabine
1
Bosentan
1
BID protein, human
1
Appointments and Schedules
1
1-dodecylpyridoxal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Advanced Solid Tumor
×
Omeprazole
×
Clear all
No trials found.